BHWM
EBS icon

Beaird Harris Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Beaird Harris Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed – – 748
2022
Q3 		$0 Hold
12
– – ﹤0.01% 496
2022
Q2 		$0 Hold
12
– – ﹤0.01% 461
2022
Q1 		$0 Hold
12
– – ﹤0.01% 636
2021
Q4 		$1K Buy
+12
New +$543 ﹤0.01% 595

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beaird Harris Wealth Management's EBS Position: Q4 2022 in Review

Beaird Harris Wealth Management sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 12 shares.

Beaird Harris Wealth Management first reported a position in EBS in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 198 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

  • Beaird Harris Wealth Management reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 12 Emergent Biosolutions shares in Q4 2022.
  • Beaird Harris Wealth Management first reported a position in Emergent Biosolutions in Q4 2021 and held it in 4 quarters.
  • Beaird Harris Wealth Management's Emergent Biosolutions position peaked at $1K in Q4 2021.
  • 198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.